<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" title="XSL_formatting" href="http://www.mstrust.org.uk/news/rss/rss.xsl"?><rss version="2.0"><channel><title><![CDATA[MS Trust News File]]></title><link><![CDATA[http://2008.mstrust.org.uk]]></link><description><![CDATA[]]></description><language><![CDATA[en-us]]></language><lastBuildDate><![CDATA[Tue, 9 Feb 2010 13:01:04 +0000]]></lastBuildDate><copyright><![CDATA[Multiple Sclerosis Trust, Spirella Building, Letchworth Garden City, Herts SG6 4ET]]></copyright><docs><![CDATA[http://blogs.law.harvard.edu/tech/rss]]></docs><generator><![CDATA[www.idnet.net]]></generator><ttl><![CDATA[60]]></ttl><item><title><![CDATA[Making information about medicines available online]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3502]]></link><description><![CDATA[The MHRA (Medicines and Healthcare products Regulatory Agency), the UK medicines' regulator, is seeking views on making information on medicines available to the public.
]]></description><pubDate><![CDATA[Tue, 9 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3502]]></guid></item><item><title><![CDATA[MP calls for abolition of the MS drugs risk-sharing scheme]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3499]]></link><description><![CDATA[The Risk-sharing Scheme, the mechanism that makes disease modifying drugs for MS available on the NHS, was debated in Parliament on 2 February.
]]></description><pubDate><![CDATA[Mon, 8 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3499]]></guid></item><item><title><![CDATA[Oral drugs for MS]]></title><link><![CDATA[http://www.mstrust.org.uk/atoz/oral_drugs.jsp]]></link><description><![CDATA[With the new oral drugs continuing to be a focus of interest, the MS Trust has put together information on the research into cladribine and fingolimod.]]></description><pubDate><![CDATA[Tue, 2 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/atoz/oral_drugs.jsp]]></guid></item><item><title><![CDATA[Experience Britain's greatest Roman monument]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3485]]></link><description><![CDATA[Visit 2,000 years of history in just one weekend
]]></description><pubDate><![CDATA[Mon, 1 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3485]]></guid></item><item><title><![CDATA[Exciting new exercise resource launched for people with MS ]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3479]]></link><description><![CDATA[Following the success of the book <em>Exercises for people with MS</em>,  the MS Trust has launched a new set of web pages full of exercises for people with MS. 
]]></description><pubDate><![CDATA[Mon, 1 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3479]]></guid></item><item><title><![CDATA[Are you a runner? Make the most of this fantastic opportunity!]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3486]]></link><description><![CDATA[The staff at Six Physio, one of the leading physio clinics in London, are raising funds for the MS Trust.  
]]></description><pubDate><![CDATA[Fri, 29 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3486]]></guid></item><item><title><![CDATA[More oral MS drug research results published]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3472]]></link><description><![CDATA[Research published in the New England Journal of Medicine (NEJM) suggests that the oral drug cladribine reduces relapse rates and disease progression in people with relapsing remitting MS.
]]></description><pubDate><![CDATA[Tue, 26 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3472]]></guid></item><item><title><![CDATA[MS Trust Running Club events for 2010]]></title><link><![CDATA[http://www.mstrust.org.uk/run]]></link><description><![CDATA[Take part in any race for the MS Trust and become part of our running club. Find out about the runs we have places in. 
]]></description><pubDate><![CDATA[Tue, 26 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/run]]></guid></item><item><title><![CDATA[Update - fampridine approved by US drugs regulator]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3464]]></link><description><![CDATA[The US Food and Drug Administration (FDA) has approved fampridine - brand name Ampyra - as a treatment to improve walking ability in people with multiple sclerosis.  
]]></description><pubDate><![CDATA[Mon, 25 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3464]]></guid></item><item><title><![CDATA[Tysabri labelling changes recommended]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3463]]></link><description><![CDATA[The European Medicines Agency has recommended new measures for dealing with the risks associated with the drug natalizumab (Tysabri).
]]></description><pubDate><![CDATA[Fri, 22 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3463]]></guid></item><item><title><![CDATA[Oral MS drug research results published]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3452]]></link><description><![CDATA[Research published online today in the New England Journal of Medicine (NEJM) suggests the new oral drug fingolimod may be more effective than current disease modifying drugs for MS.

]]></description><pubDate><![CDATA[Thu, 21 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3452]]></guid></item><item><title><![CDATA[Has MS affected your work?]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3454]]></link><description><![CDATA[The Multiple Sclerosis International Federation (MSIF) is carrying out a global survey to find out more about how having MS impacts on employment.
]]></description><pubDate><![CDATA[Wed, 20 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3454]]></guid></item><item><title><![CDATA[Fampridine submitted to licensing body]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3443]]></link><description><![CDATA[Fampridine, a new oral drug to improve walking ability in some people with multiple sclerosis, has been submitted for a licence to the EMEA, the European regulator.
]]></description><pubDate><![CDATA[Wed, 13 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3443]]></guid></item><item><title><![CDATA[MS Trust remains cautious about CCSVI]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3441]]></link><description><![CDATA[With CCSVI again in the news, the MS Trust suggests caution in considering surgery based on what is still a theory being investigated by researchers.]]></description><pubDate><![CDATA[Tue, 12 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3441]]></guid></item><item><title><![CDATA[MS Circuit Challenge at Goodwood Motor Circuit]]></title><link><![CDATA[http://www.mstrust.org.uk/fundraising/events/ukevents/goodwood/default.jsp]]></link><description><![CDATA[A fun packed day is on offer with a cycle race around the motor circuit in the morning, followed by a family event in the afternoon where you can complete the circuit "by any means"!]]></description><pubDate><![CDATA[Mon, 11 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/fundraising/events/ukevents/goodwood/default.jsp]]></guid></item><item><title><![CDATA[American researchers to explore stem cell repair procedure]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3434]]></link><description><![CDATA[Researchers in the USA are recruiting for a trial that will look at the safety and tolerability of a procedure that attempts to treat MS damage in the central nervous system with an individual's own stem cells.]]></description><pubDate><![CDATA[Fri, 8 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3434]]></guid></item><item><title><![CDATA[Run 10K for MS in 2010]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3386]]></link><description><![CDATA[Sign up now for the Great Manchester Run or the British 10K London Run. Teams of six benefit from reduced sponsorship rates! 


]]></description><pubDate><![CDATA[Thu, 7 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3386]]></guid></item><item><title><![CDATA[New higher standards agreed for MS care in Scotland]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3429]]></link><description><![CDATA[This document launched by NHS Scotland sets a new standard for neurology and MS services. We would encourage all people with MS living in Scotland to look at the full document and consider whether their local services are in line with the recommendations and appropriate for their needs.










]]></description><pubDate><![CDATA[Wed, 6 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3429]]></guid></item><item><title><![CDATA[Medications organiser iPhone app launched]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3427]]></link><description><![CDATA[A iPhone application to help people manage their injections has been developed by a man with multiple sclerosis.]]></description><pubDate><![CDATA[Tue, 5 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3427]]></guid></item><item><title><![CDATA[Challenge yourself this year with our new UK events!  ]]></title><link><![CDATA[http://www.mstrust.org.uk/fundraising/events/ukevents/default.jsp]]></link><description><![CDATA[We have lots of great events coming up this year: golf challenge, sailing, accessible cycling, walking and more! 
]]></description><pubDate><![CDATA[Tue, 5 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/fundraising/events/ukevents/default.jsp]]></guid></item><item><title><![CDATA[MS more prevalent in people born in spring]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3423]]></link><description><![CDATA[Newly published research from Scotland suggests that babies born in spring face an increased risk of developing multiple sclerosis later in life.]]></description><pubDate><![CDATA[Mon, 4 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3423]]></guid></item><item><title><![CDATA[The MS Trust welcomes review of research into cannabis ]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3413]]></link><description><![CDATA[A systematic review of randomized controlled trials has reported that cannabis can reduce spasticity in people with multiple sclerosis (MS).]]></description><pubDate><![CDATA[Wed, 23 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3413]]></guid></item><item><title><![CDATA[Revised ABN guidelines published]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3414]]></link><description><![CDATA[At long last the new Association of British Neurologists (ABN) revised (2009) guidelines for prescribing disease modifying drugs in multiple sclerosis have been published.]]></description><pubDate><![CDATA[Wed, 23 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3414]]></guid></item><item><title><![CDATA[MS Trust Christmas opening]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3412]]></link><description><![CDATA[The MS Trust Information Service will be open on the following days.]]></description><pubDate><![CDATA[Tue, 22 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3412]]></guid></item><item><title><![CDATA[Keep in touch with the MS Trust]]></title><link><![CDATA[http://www.mstrust.org.uk/about/keep_in_touch.jsp]]></link><description><![CDATA[Trying to keep up to date with MS can sometimes seem overwhelming. To help you get straight to the information you want, there are a number of ways you can have news about MS and the work of the MS Trust sent to you directly.]]></description><pubDate><![CDATA[Tue, 22 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/about/keep_in_touch.jsp]]></guid></item><item><title><![CDATA[MS Trust suggests caution about CCSVI]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3411]]></link><description><![CDATA[CCSVI (chronic cerebro-spinal venous insufficiency), the theory that an abnormal narrowing in blood vessels that take blood from the brain might be a cause of MS symptoms or perhaps MS itself, remains a widely discussed topic in the media.]]></description><pubDate><![CDATA[Tue, 22 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3411]]></guid></item><item><title><![CDATA[Road map to disability equality by 2025]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3392]]></link><description><![CDATA[The Office for Disability Issues has launched Roadmap 2025 - a document setting out how government departments are working towards disability equality by 2025.
]]></description><pubDate><![CDATA[Tue, 8 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3392]]></guid></item><item><title><![CDATA[MS Trust welcomes help for people with depression]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3393]]></link><description><![CDATA[The Department of Health has announced a new programme of support to help people with depression and mental health conditions to find and retain work.


]]></description><pubDate><![CDATA[Tue, 8 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3393]]></guid></item><item><title><![CDATA[Success For Shine On Scotland campaign]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3394]]></link><description><![CDATA[Pregnant women in Scotland will be informed about the benefits of taking vitamin D supplements following a campaign fronted by a 14-year-old Glasgow schoolboy.
]]></description><pubDate><![CDATA[Tue, 8 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3394]]></guid></item><item><title><![CDATA[MS Trust comment on the publication of Risk-sharing Scheme for MS data]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3379]]></link><description><![CDATA[The main objective of the Risk-sharing Scheme has always been to help people with MS. The Scheme is a unique initiative led by the Department of Health in conjunction with the Association of British Neurologists, the pharmaceutical industry, the MS Trust and the MS Society to give access to disease modifying drugs through the NHS. It has acted as the catalyst for the greatest improvement in MS services ever, and has thus brought tangible benefits to all people with MS across the UK.
]]></description><pubDate><![CDATA[Wed, 2 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3379]]></guid></item><item><title><![CDATA[Oral MS drug suffers set back]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3380]]></link><description><![CDATA[The US drug regulator, the US Food and Drug Administration (FDA) has 'refused to file' a license application for Cladribine, an oral disease modifying drug for relapsing/remitting multiple sclerosis.]]></description><pubDate><![CDATA[Tue, 1 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3380]]></guid></item><item><title><![CDATA[Best practice treatment recommendations for Tysabri published]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3381]]></link><description><![CDATA[A supplement in the current issue of the medical journal <em>Multiple Sclerosis</em> features a paper outlining best practice recommendations for the selection and management of people with MS receiving natalizumab (therapy).]]></description><pubDate><![CDATA[Tue, 1 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3381]]></guid></item><item><title><![CDATA[MS Trust comments on CCSVI research]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3360]]></link><description><![CDATA[CCSVI research is being widely reported in the media at present.

]]></description><pubDate><![CDATA[Wed, 25 Nov 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3360]]></guid></item><item><title><![CDATA[MS Trust wins Charity of the Week competition!]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3339]]></link><description><![CDATA[A huge thank you to everyone who voted for the MS Trust! 
]]></description><pubDate><![CDATA[Fri, 13 Nov 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3339]]></guid></item></channel></rss>
